NCT02378337View on ClinicalTrials.gov

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

CompletedOBSERVATIONAL
Enrollment

335

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

March 31, 2016

Conditions
Malignant Neoplasm of BreastHodgkin DiseaseNon-Hodgkin Lymphoma, Follicular (Nodular)Malignant Neoplasm of Bronchus and LungMalignant Neoplasm of ColonSecondary Neoplasm Malignant and Unspecified Lymph NodesMalignant Melanoma of the SkinMalignant Neoplasm of Small Intestine
Interventions
OTHER

Image quantify

Will be observed all patients who perform PET / CT examinations, independent of clinical indication, in nuclear medicine at Hospital Sao Rafael. Those who show interest in participating in the study, will be provided free and informed consent form (ICF) for your appreciation. This evaluation will serve for analysis and quantification of PET-CT images.

Trial Locations (1)

Unknown

Hospital Sao Rafael, Salvador

All Listed Sponsors
lead

Hospital Sao Rafael

OTHER

NCT02378337 - Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality | Biotech Hunter | Biotech Hunter